Biology Reference
In-Depth Information
References
Abel T, Nguyen PV, Barad M, Deuel TAS, Kandel ER (1997) Genetic demonstration of a role for
PKA in the late phase of LTP and in hippocampus based long term memory. Cell 88:615-626
Ahmed T, Frey JU (2005) Phosphodiesterase 4B (PDE4B) and cAMP-level regulation within
different tissue fractions of rat hippocampal slices during long-term potentiation in vitro. Brain
Res 1041:212-222
Aizawa T, Wei H, Miano JM, Abe J, Berk BC, Yan C (2003) Role of phosphodiesterase 3 in NO/
cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ Res 93:
406-413
Akhondzadeh S (1999) Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther 24:
241-248
Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signaling. Nat
Rev Mol Cell Biol 9:747-758
Bach ME, Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R, Mansuy I, Hawkins RD, Kandel
ER (1999) Age-related defects in spatial memory are correlated with defects in the late phase
of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the
cAMP signaling pathway. Proc Natl Acad Sci USA 96:5280-5285
Baillie GS, MacKenzie SJ, McPhee I, Houslay MD (2000) Sub-family selective actions in
the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic
AMP-specific phosphodiesterases. Br J Pharmacol 13:811-819
Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E (1998) Rolipram, a type IV-specific
phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation
and improves memory. Proc Natl Acad Sci USA 95:15020-15025
Baratti CM, Boccia MM (1999) Effects of sildenafi l on long-term retention of an inhibitory
avoidance response in mice. Behav Pharmacol 10:731-737
Barnette MS, Underwood DC (2000) New phosphodiesterase inhibitors as therapeutics for the
treatment of chronic lung disease. Curr Opin Pulm Med 6:164-169
Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to
clinical use. Pharmacol Rev 58:488-520
Birnbaum SG, Gobeske KT, Auerbach J, Taylor JR, Arnsten AFT (1999) A role for norepineph-
rine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in prefrontal cortex.
Biol Psychiatry 46:1266-1274
Blokland A, Schreiber R, Prickaerts J (2006) Improving memory: a role for phosphodiesterases.
Curr Pharm Des 12:2511-2523
Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W, de Vente J,
Prickaerts J, Blokland A, Koenig G (2004) Inhibition of phosphodiesterase 2 increases
neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 47:
1081-1092
Bolger G, Michaeli T, Martins T, St John T, Steiner B, Rodgers L, Riggs M, Wigler M, Ferguson K
(1993) A family of human phosphodiesterases homologous to the dunce learning and memory
gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol
Cell Biol 13:6558-6571
Bolger GB, Rodgers L, Riggs M (1994) Differential CNS expression of alternative mRNA
isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases. Gene 149:
237-244
Bon CL, Garthwaite J (2003) On the role of nitric oxide in hippocampal long-term potentiation.
J Neurosci 23:1941-1948
Bos JL (2006) Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31:680-686
Bourtchouladze R, Lidge R, Catapano R, Stanley J, Gossweiler S, Romashko D, Scott R (2003)
A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated
by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 100:10518-10522
